Pharmacokinetics and dialysability of is
β
K. SchΓΆnholzer; C. Marone
π
Article
π
1992
π
Springer
π
English
β 258 KB
The pharmacokinetics of isradipine, a calcium-channel blocker, have been studied in eight patients on chronic haemodialysis. A single oral dose of 5 mg was administered on both a non-haemodialysis and a haemodialysis day and the plasma concentrations of isradipine were analyzed. The mean cmax, tmax,